CIK 0001124105
- Accelerated filer
- Smaller reporting company
GYRE THERAPEUTICS, INC.
Sign in to watch- Ticker
- GYRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 562020050
- Phone
- +1 858-284-0115
- Business address
- 12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
- Former names
- CATALYST BIOSCIENCES, INC., TARGACEPT INC
- 4 Planned sale President sold 2,182 shares at an average $10.91 ($23,804)
- 4 Planned sale President sold 4,000 shares at an average $11.04 ($44,160)
- 4 Planned sale President sold 4,000 shares at an average $11.21 ($44,840)
- 4 Planned sale President sold 2,020 shares at an average $10.69 ($21,586)
- 4 Exercise or conversion Chief Operating Officer acquired 50,000 shares (option exercise)
- 4 Planned sale President sold 4,000 shares at an average $10.97 ($43,860)
- 4 Exercise or conversion Chief Operating Officer acquired 650,000 shares (option exercise)
- 4 Exercise or conversion Director acquired 15,000 shares (option exercise)
- 4 Planned sale President sold 174 shares at $10.00 ($1,740)
- 4 Planned sale President sold 4,000 shares at an average $10.11 ($40,440)
- 4 Planned sale President sold 2,242 shares at an average $11.89 ($26,658)
- 4 Planned sale President sold 4,000 shares at an average $12.06 ($48,220)
- 4 Planned sale President sold 4,000 shares at an average $11.57 ($46,280)
- 4 Derivatives Options or other derivatives
- 4 Planned sale President sold 4,000 shares at an average $10.19 ($40,776)
- 4 Planned sale President sold 4,000 shares at an average $10.89 ($43,560)
- 4 Planned sale President sold 4,000 shares at an average $11.05 ($44,180)
- 4 Planned sale President sold 4,000 shares at an average $11.37 ($45,480)
- 4 Planned sale President sold 4,000 shares at an average $11.50 ($46,000)
- 4 Planned sale President sold 4,000 shares at an average $11.30 ($45,190)
Page 3 of 37 · 739 filings